SLC25A10
Basic information
Region (hg38): 17:81712236-81721016
Previous symbols: [ "DIC" ]
Links
Phenotypes
GenCC
Source:
- mitochondrial DNA depletion syndrome 19 (Moderate), mode of inheritance: AR
- mitochondrial DNA depletion syndrome 19 (Limited), mode of inheritance: Unknown
- mitochondrial disease (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Mitochondrial DNA depletion syndrome 19 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Neurologic | 29211846 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (59 variants)
- not_provided (12 variants)
- Mitochondrial_DNA_depletion_syndrome_19 (4 variants)
- SLC25A10-related_disorder (1 variants)
- Mitochondrial_complex_I_deficiency (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC25A10 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000012140.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | |||||
| missense | 56 | 62 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 9 | |||||
| Total | 0 | 3 | 66 | 9 | 2 |
Highest pathogenic variant AF is 0.00001314717
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SLC25A10 | protein_coding | protein_coding | ENST00000331531 | 11 | 17639 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 4.86e-7 | 0.644 | 125710 | 0 | 36 | 125746 | 0.000143 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.625 | 167 | 191 | 0.873 | 0.0000134 | 1872 |
| Missense in Polyphen | 54 | 66.387 | 0.81342 | 615 | ||
| Synonymous | 0.0434 | 81 | 81.5 | 0.994 | 0.00000618 | 623 |
| Loss of Function | 1.08 | 12 | 16.8 | 0.715 | 8.03e-7 | 193 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000249 | 0.000243 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.000416 | 0.000416 |
| European (Non-Finnish) | 0.000159 | 0.000158 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000653 | 0.0000653 |
| Other | 0.000333 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in translocation of malonate, malate and succinate in exchange for phosphate, sulfate, sulfite or thiosulfate across mitochondrial inner membrane.;
- Pathway
- Proximal tubule bicarbonate reclamation - Homo sapiens (human);The oncogenic action of Succinate;The oncogenic action of Fumarate;Metabolism of carbohydrates;Sulfide oxidation to sulfate;Degradation of cysteine and homocysteine;Metabolism of amino acids and derivatives;Glycolysis and Gluconeogenesis;Purine metabolism;Metabolism;Organic anion transporters;Amino acid and oligopeptide SLC transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Methionine and cysteine metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Butanoate metabolism;Gluconeogenesis;Glucose metabolism;Sulfur amino acid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.127
Intolerance Scores
- loftool
- 0.537
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24.19
Haploinsufficiency Scores
- pHI
- 0.183
- hipred
- N
- hipred_score
- 0.239
- ghis
- 0.516
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.742
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc25a10
- Phenotype
Gene ontology
- Biological process
- gluconeogenesis;ion transport;dicarboxylic acid transport;mitochondrial transport;sulfate transport;thiosulfate transport;oxaloacetate transport;phosphate ion transmembrane transport;sulfide oxidation, using sulfide:quinone oxidoreductase;succinate transmembrane transport;malate transmembrane transport;oxaloacetate(2-) transmembrane transport;sulfate transmembrane transport
- Cellular component
- nucleus;nucleoplasm;mitochondrion;mitochondrial inner membrane;integral component of membrane
- Molecular function
- dicarboxylic acid transmembrane transporter activity;protein binding;sulfate transmembrane transporter activity;thiosulfate transmembrane transporter activity;oxaloacetate transmembrane transporter activity;malate transmembrane transporter activity;succinate transmembrane transporter activity;antiporter activity